DAUNOrubicin and Cytarabine and NovoLog FlexPen
Determining the interaction of DAUNOrubicin and Cytarabine and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DAUNOrubicin and Cytarabine-Novolog Injection
- DAUNOrubicin and Cytarabine-NovoLog Mix 70/30
- DAUNOrubicin and Cytarabine-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- DAUNOrubicin and Cytarabine-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- DAUNOrubicin and Cytarabine-NovoLog Mix 70/30 FlexPen
- DAUNOrubicin and Cytarabine-NovoLog PenFill
- NovoLog FlexPen-Daunorubicin and Cytarabine (Liposomal)
- NovoLog FlexPen-Daunorubicin and cytarabine liposome Intravenous
- NovoLog FlexPen-Daunorubicin citrate
- NovoLog FlexPen-Daunorubicin citrate liposome Intravenous
- NovoLog FlexPen-Daunorubicin hydrochloride
- NovoLog FlexPen-Daunorubicin Intravenous